Moneta Group Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Sell |
450
-340
| -43% | -$179K | ﹤0.01% | 620 |
|
|
2025
Q1 | $501K | Buy |
790
+39
| +5% | +$24.7K | 0.01% | 419 |
|
|
2024
Q4 | $535K | Sell |
751
-107
| -12% | -$76.2K | 0.01% | 400 |
|
|
2024
Q3 | $902K | Buy |
858
+21
| +3% | +$22.1K | 0.01% | 290 |
|
|
2024
Q2 | $880K | Buy |
837
+159
| +23% | +$167K | 0.01% | 285 |
|
|
2024
Q1 | $653K | Buy |
678
+109
| +19% | +$105K | 0.01% | 329 |
|
|
2023
Q4 | $500K | Sell |
569
-2
| -0.4% | -$1.76K | 0.01% | 340 |
|
|
2023
Q3 | $470K | Sell |
571
-3
| -0.5% | -$2.47K | 0.01% | 330 |
|
|
2023
Q2 | $412K | Sell |
574
-69
| -11% | -$49.6K | 0.01% | 365 |
|
|
2023
Q1 | $528K | Buy |
643
+127
| +25% | +$104K | 0.01% | 314 |
|
|
2022
Q4 | $391K | Sell |
516
-489
| -49% | -$371K | 0.01% | 331 |
|
|
2022
Q3 | $692K | Sell |
1,005
-2
| -0.2% | -$1.38K | 0.03% | 227 |
|
|
2022
Q2 | $595K | Buy |
1,007
+453
| +82% | +$268K | 0.02% | 278 |
|
|
2022
Q1 | $387K | Buy |
+554
| New | +$387K | 0.02% | 322 |
|